Clinical Trials Directory

Trials / Completed

CompletedNCT06079645

Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique)

Triamcinolone Acetonide Injections Compared With Micro Injections (MMP Technique) of Triamcinolone Acetonide for the Treatment of Female Genital Lichen Sclerosus and Atrophic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Clinica Dermatologica Arbache ltda · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research is about a genital disease known as Lichem Sclerosus and Atrophic. It mainly affects women over 18 years of age. The treatment will involve injections of a medicine that contains cortisone, using two different methods: with a syringe and a needle or with a tattoo machine. Before and after treatment, they will see if women feel pain, itching, burning, scratching or difficulty having sexual intercourse.

Detailed description

There is evidence that injectable triamcinolone has an effect on reducing the symptoms of lichen sclerosus and atrophic. After randomizing the vulva, the vulva will be anesthetized with lidocaine infiltrations. After 15 minutes, interventions will begin. Triamcinolone will be injected using two different techniques: syringes \& needles in one side and with tattoo machine (MMP technique) in other side. The outcomes will be evaluated according to the criteria of pain, itching, burning, itching and difficulty in sexual penetration

Conditions

Interventions

TypeNameDescription
PROCEDUREInfiltration of triamcinolone acetonide (2mg/ml) through syringes and needlesInfiltration of triamcinolone acetonide (2mg/ml) through syringes and needles
PROCEDUREInfiltration of triamcinolone acetonide (40 mg/ml) with needlesInfiltration of triamcinolone acetonide (40 mg/ml) through needles of tattoo machine

Timeline

Start date
2023-10-20
Primary completion
2025-05-14
Completion
2025-06-14
First posted
2023-10-12
Last updated
2026-01-21

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06079645. Inclusion in this directory is not an endorsement.